Although one may think of psychedelic pharmaceuticals as being dangerous and detrimental, scientists have been conducting experiments and clinical trials on some of them and have obtained positive results when testing them for medical use. Research has shown that drugs such as MDMA (a type of methamphetamine), LSD and psilocybin (“magic mushrooms”) can be of benefit in treating severe pain, anxiety, depression and certain mental illnesses.
Successful outcomes have been achieved when using psychedelics for treating conditions such as post-traumatic stress disorder and addictions to alcohol and smoking, for example. In many cases, these treatments have benefited individuals who had unsuccessfully tried to treat their conditions by other methods.
Experts have cautioned, however, that treatments using psychedelic pharmaceuticals must be administered under very carefully controlled conditions, with dosages precisely monitored and given in a prescribed manner. A drug delivery system that can fulfill these needs would offer a clear advantage over standard methods such as oral administration, injections or topical and nasal delivery.
The Terasaki Institute for Biomedical Innovation (TIBI) offers a microneedle patch for drug delivery that can be finely tuned for dosage and timed release…